<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Data</journal-id>
    <journal-title-group>
      <journal-title>Scientific Data</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2052-4463</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9418253</article-id>
    <article-id pub-id-type="publisher-id">1654</article-id>
    <article-id pub-id-type="doi">10.1038/s41597-022-01654-2</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Data Descriptor</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4794-0134</contrib-id>
        <name>
          <surname>Kuo</surname>
          <given-names>Tien-Chueh</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Pei-Hua</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Yu-Ke</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chang</surname>
          <given-names>Chia-I.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chang</surname>
          <given-names>Ching-Yao</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Tseng</surname>
          <given-names>Yufeng Jane</given-names>
        </name>
        <address>
          <email>yjtseng@csie.ntu.edu.tw</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.19188.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0546 0241</institution-id><institution>The Metabolomics Core Laboratory, Center of Genomic Medicine, </institution><institution>National Taiwan University, </institution></institution-wrap>No. 1, Sec. 4, Roosevelt Road, Taipei, 10617 Taiwan </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.19188.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0546 0241</institution-id><institution>Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, </institution><institution>National Taiwan University, </institution></institution-wrap>No. 1, Sec. 4, Roosevelt Road, Taipei, 10617 Taiwan </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.19188.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0546 0241</institution-id><institution>Department of Computer Science and Information Engineering, College of Electrical Engineering and Computer Science, </institution><institution>National Taiwan University, </institution></institution-wrap>No. 1, Sec. 4, Roosevelt Road, Taipei, 10617 Taiwan </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>8</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>9</volume>
    <elocation-id>521</elocation-id>
    <history>
      <date date-type="received">
        <day>27</day>
        <month>1</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>19</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Rare skin diseases include more than 800 diseases affecting more than 6.8 million patients worldwide. However, only 100 drugs have been developed for treating rare skin diseases in the past 38 years. To investigate potential treatments through drug repurposing for rare skin diseases, it is necessary to have a well-organized database to link all known disease causes, mechanisms, and related information to accelerate the process. Drug repurposing provides less expensive and faster potential options to develop treatments for known diseases. In this work, we designed and constructed a rare skin disease database (RSDB) as a disease-centered information depository to facilitate repurposing drug candidates for rare skin diseases. We collected and integrated associated genes, chemicals, and phenotypes into a network connected by pairwise relationships between different components for rare skin diseases. The RSDB covers 891 rare skin diseases defined by the Orphanet and GARD databases. The organized network for each rare skin disease comprises associated genes, phenotypes, and chemicals with the corresponding connections. The RSDB is available at <ext-link ext-link-type="uri" xlink:href="https://rsdb.cmdm.tw">https://rsdb.cmdm.tw</ext-link>.</p>
    </abstract>
    <abstract id="Abs2" abstract-type="summary">
      <p id="Par2">
        <table-wrap id="Taba">
          <table frame="hsides" rules="groups">
            <tbody>
              <tr>
                <td>Measurement(s)</td>
                <td>Relationships between chemicals and genes • Relationships between diseases and genes • Relationships between diseases and phenotypes • Relationships between genes and phenotypes</td>
              </tr>
              <tr>
                <td>Technology Type(s)</td>
                <td>The Comparative Toxicogenomics Database (CTD) and DrugBank • DisGeNET, UniProt, The Comparative Toxicogenomics Database (CTD), Orphanet, ClinGen, Genomics England, NCBI ClinVar, The Human Phenotype Ontology (HPO), the GWAS Catalog, GWASdb28, the LHGDN and BeFree system • The Human Phenotype Ontology (HPO) and Genetic and Rare Diseases Information Center (GARD)</td>
              </tr>
              <tr>
                <td>Sample Characteristic - Organism</td>
                <td>Homo sapiens</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Bioinformatics</kwd>
      <kwd>Drug development</kwd>
      <kwd>Target identification</kwd>
      <kwd>Databases</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004663</institution-id>
            <institution>Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MOST109-2823-8-002-010-CV, MOST 109-2320-B-002-040-, MOST 110-2320-B-002-038-</award-id>
        <principal-award-recipient>
          <name>
            <surname>Tseng</surname>
            <given-names>Yufeng Jane</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100009210</institution-id>
            <institution>Ministry of Health and Welfare, Taiwan | Food and Drug Administration (Taiwan Food and Drug Administration)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>MOHW110-FDA-D-114-000611</award-id>
        <principal-award-recipient>
          <name>
            <surname>Tseng</surname>
            <given-names>Yufeng Jane</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100006477</institution-id>
            <institution>National Taiwan University (NTU)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>NTU-CC-110L890803, NTU-110L8809</award-id>
        <principal-award-recipient>
          <name>
            <surname>Tseng</surname>
            <given-names>Yufeng Jane</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background &amp; Summary</title>
    <p id="Par3">Rare diseases affect fewer than 1 in 200,000 people in the U.S. or 1 in 2,000 people in Europe<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Although most rare diseases are complex, disabling, and life-threatening<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, they lack related studies and approved treatments<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> due to the limited prevalence and market<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Skin diseases cause significant nonfatal disability worldwide<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, especially in resource-poor regions<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. However, far little attention has been given to rare skin diseases<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. In addition to the physiological burden, skin diseases’ economic and social impacts significantly lower patients’ quality of life<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>. Therefore, this work aims to help link drugs to drug targets for rare skin diseases.</p>
    <p id="Par4">Two databases, Orphanet and GARD, provide curated information on the diagnosis and currently available treatments for rare diseases<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Orphanet (<ext-link ext-link-type="uri" xlink:href="http://www.orpha.net">www.orpha.net</ext-link>) covers rare diseases and orphan drugs, gathering and providing complete information and knowledge to improve diagnosis<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. GARD, the Genetic and Rare Diseases Information Center, is a National Center for Advancing Translational Sciences (NCATS) program in the United States. It was established by the National Institutes of Health (N.I.H.) to provide information about symptoms, prevalence statistics, causes, treatments, diagnosis, and the latest research resources for over 6500 rare diseases<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>.</p>
    <p id="Par5">Although genetics accounts for the various causes of skin symptoms, the challenges of rare skin diseases are that they cannot be easily classified as skin disorders with a fixed set of symptoms. These symptoms vary from disease to disease and among patients with the same disease. Epidermolysis bullosa (E.B.) is a family of devastating rare skin diseases with friction inflicting painful, open wounds within the skin and internal epithelial tissue blistering<sup><xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup>. Recent E.B. research has led to identifying mutations in 10 different genes<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. One of the most severe forms of E.B. is recessive dystrophic epidermolysis bullosa (RDEB), caused by mutations in a protein called collagen VII<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Collagen VII provides the skin with structural integrity. There are over 500,000 people worldwide who suffer from this debilitating disorder. Simply looking at a single mutation or open wound would not help identify the disease or the treatment. Expansion of the symptoms (phenotypes) to look for more probable treatment is needed.</p>
    <p id="Par6">Drug repurposing can reduce the risk of failure and the massive cost of money and time in drug development by identifying new indications for an existing drug that is already approved<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. Drug repurposing aims to find new relationships between the drug and disease<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. However, related data regarding rare skin diseases are scattered and stored in several biomedical databases. Most patient-centered databases provide diagnostic criteria or currently available treatments and prognoses. We collected and integrated associated genes, chemicals, and phenotypes into a network to find novel drug-disease relationships for rare skin diseases. The rare skin disease database (RSDB) covers 891 rare skin diseases defined by the Orphanet and GARD databases. The organized network for each rare skin disease comprises associated genes, phenotypes, and chemicals connected via associations found in PubChem<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, MeSH<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, the Comparative Toxicogenomics Database (CTD)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>, and Human Phenotype Ontology (HPO)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. The RSDB is available at <ext-link ext-link-type="uri" xlink:href="https://rsdb.cmdm.tw">https://rsdb.cmdm.tw</ext-link>.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <p id="Par7">We collected data from public databases containing curated, inferred, literature-based information to create a database for connecting biomedical information. With curated disease genes, phenotypes, and phenotype genes as the direct molecular signatures of rare skin diseases, this work tries to link potential drugs to candidate rare skin disease targets with matched genes through disease-gene or disease-phenotype-gene relationships.</p>
    <p id="Par8">Currently, the RSDB contains 891 rare skin diseases, 28,077 genes, 9,732 phenotypes and 17,297 compounds with 16,411 disease-gene relationships, 15,793 disease-phenotype relationships, 12,184 disease-reference relationships, 641,789 gene-phenotype relationships, 17,636 gene-reference relationships and 61,282 references. The RSDB will be updated twice a year in June and December.</p>
    <p id="Par9">Users can visit the RSDB homepage (<ext-link ext-link-type="uri" xlink:href="https://rsdb.cmdm.tw">https://rsdb.cmdm.tw</ext-link>) to explore the data for rare skin disease information. On the RSDB website, users can access records and perform searches (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Search engine and homepage of the RSDB.</p></caption><graphic xlink:href="41597_2022_1654_Fig1_HTML" id="d32e452"/></fig></p>
    <sec id="Sec3">
      <title>Chemicals</title>
      <p id="Par10">A total of 17,297 environmental chemicals including approved drugs, were imported from the dataset of chemicals to genes in the CTD and DrugBank. All chemicals associated with genes are included in the RSDB.</p>
    </sec>
    <sec id="Sec4">
      <title>Diseases</title>
      <p id="Par11">Rare skin diseases were collected from Orphanet and GARD. Orphanet provides the disease classifications. All the rare diseases classified to the skin class were parsed and stored in the database.</p>
      <p id="Par12">The skin disease category was derived from NIH GARD. To determine whether a disease is a rare skin disease, we compared Orphanet as a basis. All information was downloaded, including the synonyms, definitions, inheritance, prevalence, and genes related to the disease. According to the NIH GARD, we found that 619 skin diseases have been described.</p>
    </sec>
    <sec id="Sec5">
      <title>Genes and disease-gene relationships</title>
      <p id="Par13">Associated disease-gene relationships were collected from DisGeNET v7<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. DisGeNET provides three tiers: (1) expert-curated information, (2) inferred information, and (3) text-mining information. Expertly curated information was collected from UniProt, the CTD, Orphanet, ClinGen, and Genomics England. (2) Inferred information was collected from NCBI ClinVar, HPO, the GWAS Catalog, and GWASdb<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. (3) Text-mining information was collected from the LHGDN and BeFree system.</p>
    </sec>
    <sec id="Sec6">
      <title>Phenotypes and disease-phenotype and gene-phenotype relationships</title>
      <p id="Par14">Associated phenotypes were collected from HPO and GARD. HPO provides disease-phenotype and gene-phenotype information. GARD provides rare disease-to-phenotype relationship information. We downloaded the 2020-12 version.</p>
    </sec>
    <sec id="Sec7">
      <title>References</title>
      <p id="Par15">Associated references were collected from the literature section of PubChem, which is linked to PubMed.</p>
    </sec>
    <sec id="Sec8">
      <title>Source database</title>
      <p id="Par16">All data from different public databases were collected as follows.</p>
    </sec>
    <sec id="Sec9">
      <title>Expertly curated information</title>
      <p id="Par17">UniProt<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, the CTD<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, Orphanet<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, ClinGen<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, Genomics England<sup><xref ref-type="bibr" rid="CR33">33</xref></sup></p>
      <p id="Par18">The CTD includes manually curated data on how chemicals interact with genes and proteins. Specifically, a chemical compound may interact with a gene or protein and influence its expression, folding, localization, activity, binding, abundance, and metabolic processing.</p>
    </sec>
    <sec id="Sec10">
      <title>Inferred information</title>
      <p id="Par19">NCBI ClinVar<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, HPO<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, the Genome-Wide Association Study (GWAS) Catalog<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>.</p>
    </sec>
    <sec id="Sec11">
      <title>Literature-based information</title>
      <p id="Par20">The literature-derived human gene-disease network (LHGDN)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, BeFree system<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p>
    </sec>
  </sec>
  <sec id="Sec12">
    <title>Data Records</title>
    <p id="Par21">All the data files in RSDB are stored in the Synapse repository (10.7303/syn34512708)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> and are available under the terms of CC BY-NC-SA 4.0 (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">https://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).</p>
    <p id="Par22">There are 22 CSV files in the repository. Among them are nine files describing the basic components in RSDB, including compounds, genes, phenotypes, etc. The other 13 files store the pairwise relationships between components.</p>
    <p id="Par23">We designated an internal ID for all the files to every entry in the first column. For the files describing basic components, associated properties like names, descriptions, and ID numbers from other databases will be stored in the following columns. For the files describing relationships, we separate the many-to-many relationships in RSDB into multiple entries of pairwise relationships. For example, disease_gene_relationships.csv stores internal disease ID and gene ID in the first and second columns, respectively. Disease with internal ID 3 is linked to the genes with internal ID 3 and 4 in the third and fourth entries. One can refer to diseases.csv and genes.csv for more information about the disease and genes involved in the relationships.</p>
  </sec>
  <sec id="Sec13">
    <title>Technical Validation</title>
    <p id="Par24">The datasets were retrieved from several public databases. According to the source database, the information we provide is curated by an expert or inferred from the literature or experiments. For example, our database connected four genes to the rare skin disease “exfoliative ichthyosis”: CSTA, KRT1, KRT2, and SERPINB8. Mutation in CSTA, which encodes cystatin A, can cause the disease<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Genetic linkages between the disease and KRT1 and KRT2, encoding keratin 1 and 2<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, respectively. Loss-of-function mutations in SERPINB8, encoding serpin B8, are also linked to exfoliative ichthyosis<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. The rare skin disease “epidermolytic palmoplantar keratoderma” has been confirmed to be caused by mutations in KRT1<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, KRT9<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, and KRT16<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. This literature, which proves the accuracy of the disease-gene relationships in our data, is also provided to users via links to PubMed.</p>
    <p id="Par25">Here we demonstrate how our database can help drug repurposing using the well-known case of diacerein. Diacerein is a symptomatic drug in osteoarthritis. Its active metabolite, Rhein, decreases inflammation, reduces damage, and promotes the formation of new cartilage<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Diacerein has been effective against epidermolysis bullosa (EB) in the past decade by reducing blister counts and increasing skin stability<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. There are four main types of EB, namely EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB), and Kindler syndrome (KS), according to the current international consensus classification. In RSDB, five genes directly link to chemical diacerein: ACAN, COL1A1, COL2A1, and IL1B. Among them, COL1A1 and COL2A2 are linked to “dystrophic epidermolysis bullosa” (DEB) and “localized dystrophic epidermolysis bullosa, pretibial form,” a subtype of DEB, respectively. This validates our data and shows the possibility of finding a potential drug for repurposing.</p>
    <p id="Par26">The RSDB includes all the pairwise relationships between disease, gene, phenotype, and chemical-disease and chemical-gene associations. For a particular rare skin disease, the profile of the disease and lists of associated genes, phenotypes, or chemicals are provided along with network visualization. Integrated information that only multiple searches across several databases can obtain is organized into one webpage. Crosslinks to other databases and related articles in PubMed facilitate further analysis and study.</p>
    <p id="Par27">One outstanding feature of the RSDB is network visualization. Diseases, phenotypes, genes, and chemicals are denoted by pink squares, gray triangles, blue circles, and orange hexagons, respectively. For the network containing more than 50 nodes, the CiSE layout<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> will be applied to generate several circular layouts for each type of node to visualize the entire network without overlapping nodes. Otherwise, the fCoSE layout<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> will be applied. In addition, several layout algorithms, including circle, concentric, and CoSE layouts, are also available for users to change different network layouts. To access the node name and the link to the node page, users can click on the node, and the node information and link will appear in the tooltip. To pan, zoom in and out of the network, a navigation toolbar is provided on the top-left of the network. Network visualization helps users find genes and phenotypes relevant to particular rare skin diseases.</p>
    <p id="Par28">A gene can be indirectly linked to a disease in the network if both nodes are connected to the same phenotype, an intermediate node. For example, the gene “NOTCH1”, shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>, links to the disease directly and indirectly through a phenotype with HPO ID 25107. Multiple sources that lead to the same connection between one pair of diseases and genes imply a strong relationship between the disease and gene. We hope these findings help scientists find promising research targets and accelerate orphan drug discovery.<fig id="Fig2"><label>Fig. 2</label><caption><p>Screenshot of the network for cutis marmorata telangiectatica congenita (ORPHA: 1556). Nine phenotypes, two genes, and one chemical are directly connected to the disease, and eight genes are indirectly linked to the disease through phenotypes. The <italic>NOTCH1</italic> gene is related to the disease both directly and indirectly. Red edge stands for the curated disease-gene information.</p></caption><graphic xlink:href="41597_2022_1654_Fig2_HTML" id="d32e644"/></fig></p>
    <p id="Par29">We developed a disease-centered database covering 891 rare skin diseases with associated genes, phenotypes, and chemicals. We deployed a complete text search engine to include exact matches and fuzzy searches for the search terms. On each chemical/disease/gene/phenotype page, all associated chemical/disease/gene/phenotype information is connected and visualized in the network. In the associated chemical/disease/gene/phenotype tables, all associated data will be listed with data source and evidence. The associated data can be filtered with keywords via the top-right search form of the tables.</p>
  </sec>
  <sec id="Sec14">
    <title>Usage Notes</title>
    <sec id="Sec15">
      <title>Overview of the RSDB</title>
      <p id="Par30">We designed the RSDB with critical components, including (1) rare skin diseases, (2) genes, (3) phenotypes, and (4) chemicals. All four elements were collected from manually curated databases and connected with the associated information. All related information of one disease is seen as the molecular signature of the disease. An entity-relationship diagram is displayed in Fig. <xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig3"><label>Fig. 3</label><caption><p>Entity-relationship diagram of the RSDB.</p></caption><graphic xlink:href="41597_2022_1654_Fig3_HTML" id="d32e666"/></fig></p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We appreciate Dr. Yiumo Michael Chan for providing comments that improved the database. This work was supported by the Taiwan Ministry of Science and Technology (MOST 109-2823-8-002-010-CV, MOST 109-2320-B-002-040-, MOST 110-2320-B-002-038-); Taiwan Food and Drug Administration (MOHW110-FDA-D-114-000611); and National Taiwan University (NTU-CC-110L890803, NTU-110L8809). We thank the Laboratory of Computational Molecular Design and Metabolomics and the Department of Computer Science and Information Engineering of National Taiwan University for the resources used in performing these studies.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>Y.J.T. conceived the project. T.C.K., P.H.W., Y.K.W. and C.I.C. collected the data. T.C.K., P.H.W., Y.K.W., C.I.C. and Y.J.T. wrote the manuscript. T.C.K. designed and implemented the database. C.Y.C. implemented the database.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Code availability</title>
    <p>The code supporting this study’s findings is available on GitHub at <ext-link ext-link-type="uri" xlink:href="https://github.com/CMDM-Lab/rsdb_publication">https://github.com/CMDM-Lab/rsdb_publication</ext-link>.</p>
    <p>The scripts and packages used for the RSDB rely on open-source packages such as Ruby on Rails, MariaDB, ElasticSearch, Cytoscape.js<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, and in-house Ruby scripts.</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par31">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boycott</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Vanstone</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Bulman</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>MacKenzie</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>Rare-disease genetics in the era of next-generation sequencing: discovery to translation</article-title>
        <source>Nat Rev Genet</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>681</fpage>
        <lpage>691</lpage>
        <pub-id pub-id-type="doi">10.1038/nrg3555</pub-id>
        <?supplied-pmid 23999272?>
        <pub-id pub-id-type="pmid">23999272</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simone Baldovino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Domenica Taruscio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dario Roccatello</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Rare diseases in Europe: from a wide to a local perspective</article-title>
        <source>Sat</source>
        <year>2016</year>
        <volume>12</volume>
        <fpage>20</fpage>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Navarrete-Opazo</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tisdale</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cutillo</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Garrison</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>Can you hear us now? The impact of health-care utilization by rare disease patients in the United States</article-title>
        <source>Genetics in Medicine</source>
        <year>2021</year>
        <volume>23</volume>
        <fpage>2194</fpage>
        <lpage>2201</lpage>
        <pub-id pub-id-type="doi">10.1038/s41436-021-01241-7</pub-id>
        <?supplied-pmid 34183788?>
        <pub-id pub-id-type="pmid">34183788</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoeger</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Genes and phenotypes in vascular malformations</article-title>
        <source>Clinical and Experimental Dermatology</source>
        <year>2021</year>
        <volume>46</volume>
        <fpage>495</fpage>
        <lpage>502</lpage>
        <pub-id pub-id-type="doi">10.1111/ced.14513</pub-id>
        <?supplied-pmid 33368487?>
        <pub-id pub-id-type="pmid">33368487</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sardana</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Drug repositioning for orphan diseases</article-title>
        <source>Briefings in bioinformatics</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>346</fpage>
        <lpage>356</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbr021</pub-id>
        <?supplied-pmid 21504985?>
        <pub-id pub-id-type="pmid">21504985</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hay</surname>
            <given-names>RJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions</article-title>
        <source>Journal of Investigative Dermatology</source>
        <year>2014</year>
        <volume>134</volume>
        <fpage>1527</fpage>
        <lpage>1534</lpage>
        <pub-id pub-id-type="doi">10.1038/jid.2013.446</pub-id>
        <?supplied-pmid 24166134?>
        <pub-id pub-id-type="pmid">24166134</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seth</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cheldize</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>EE</given-names>
          </name>
        </person-group>
        <article-title>Global burden of skin disease: inequities and innovations</article-title>
        <source>Current dermatology reports</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>204</fpage>
        <lpage>210</lpage>
        <pub-id pub-id-type="doi">10.1007/s13671-017-0192-7</pub-id>
        <?supplied-pmid 29226027?>
        <pub-id pub-id-type="pmid">29226027</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McGrath</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Rare inherited skin diseases and the Genomics England 100,000 Genome Project</article-title>
        <source>British Journal of Dermatology</source>
        <year>2016</year>
        <volume>174</volume>
        <fpage>257</fpage>
        <lpage>258</lpage>
        <pub-id pub-id-type="doi">10.1111/bjd.14362</pub-id>
        <?supplied-pmid 26871914?>
        <pub-id pub-id-type="pmid">26871914</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Finlay</surname>
            <given-names>AY</given-names>
          </name>
        </person-group>
        <article-title>The burden of skin disease: quality of life, economic aspects and social issues</article-title>
        <source>Clinical Medicine</source>
        <year>2009</year>
        <volume>9</volume>
        <fpage>592</fpage>
        <pub-id pub-id-type="doi">10.7861/clinmedicine.9-6-592</pub-id>
        <?supplied-pmid 20095308?>
        <pub-id pub-id-type="pmid">20095308</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>X-j</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The psychosocial adaptation of patients with skin disease: a scoping review</article-title>
        <source>BMC public health</source>
        <year>2019</year>
        <volume>19</volume>
        <fpage>1</fpage>
        <lpage>15</lpage>
        <pub-id pub-id-type="doi">10.1186/s12889-018-6343-3</pub-id>
        <pub-id pub-id-type="pmid">30606151</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Rare disease knowledge enrichment through a data-driven approach</article-title>
        <source>BMC medical informatics and decision making</source>
        <year>2019</year>
        <volume>19</volume>
        <fpage>1</fpage>
        <lpage>11</lpage>
        <pub-id pub-id-type="doi">10.1186/s12911-019-0752-9</pub-id>
        <?supplied-pmid 30616584?>
        <pub-id pub-id-type="pmid">30616584</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rath</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users</article-title>
        <source>Human mutation</source>
        <year>2012</year>
        <volume>33</volume>
        <fpage>803</fpage>
        <lpage>808</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.22078</pub-id>
        <?supplied-pmid 22422702?>
        <pub-id pub-id-type="pmid">22422702</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Q</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)</article-title>
        <source>Journal of Biomedical Semantics</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1186/s13326-020-00232-y</pub-id>
        <pub-id pub-id-type="pmid">31931870</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mellerio</surname>
            <given-names>JE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Emergency management in epidermolysis bullosa: consensus clinical recommendations from the European reference network for rare skin diseases</article-title>
        <source>Orphanet Journal of Rare Diseases</source>
        <year>2020</year>
        <volume>15</volume>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1186/s13023-020-01403-x</pub-id>
        <pub-id pub-id-type="pmid">31900176</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Montaudié</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chiaverini</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sbidian</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Charlesworth</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lacour</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases</article-title>
        <source>Orphanet journal of rare diseases</source>
        <year>2016</year>
        <volume>11</volume>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1186/s13023-016-0489-9</pub-id>
        <pub-id pub-id-type="pmid">26728142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prodinger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Laimer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bauer</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Hintner</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>EB (epidermolysis bullosa)‐House Austria: Pioneering work for the care of patients with rare diseases</article-title>
        <source>JDDG: Journal der Deutschen Dermatologischen Gesellschaft</source>
        <year>2020</year>
        <volume>18</volume>
        <fpage>1229</fpage>
        <lpage>1235</lpage>
        <?supplied-pmid 33251730?>
        <pub-id pub-id-type="pmid">33251730</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chiu</surname>
            <given-names>FC</given-names>
          </name>
          <name>
            <surname>Doolan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>McGrath</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Onoufriadis</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>A decade of next‐generation sequencing in genodermatoses: the impact on gene discovery and clinical diagnostics</article-title>
        <source>British Journal of Dermatology</source>
        <year>2021</year>
        <volume>184</volume>
        <fpage>606</fpage>
        <lpage>616</lpage>
        <pub-id pub-id-type="doi">10.1111/bjd.19384</pub-id>
        <?supplied-pmid 32628274?>
        <pub-id pub-id-type="pmid">32628274</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sawamura</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Nakano</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Matsuzaki</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Overview of epidermolysis bullosa</article-title>
        <source>The Journal of dermatology</source>
        <year>2010</year>
        <volume>37</volume>
        <fpage>214</fpage>
        <lpage>219</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1346-8138.2009.00800.x</pub-id>
        <?supplied-pmid 20507384?>
        <pub-id pub-id-type="pmid">20507384</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa</article-title>
        <source>Journal of Investigative Dermatology</source>
        <year>2008</year>
        <volume>128</volume>
        <fpage>2179</fpage>
        <lpage>2189</lpage>
        <pub-id pub-id-type="doi">10.1038/jid.2008.78</pub-id>
        <?supplied-pmid 18385758?>
        <pub-id pub-id-type="pmid">18385758</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oprea</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mestres</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Drug repurposing: far beyond new targets for old drugs</article-title>
        <source>The AAPS journal</source>
        <year>2012</year>
        <volume>14</volume>
        <fpage>759</fpage>
        <lpage>763</lpage>
        <pub-id pub-id-type="doi">10.1208/s12248-012-9390-1</pub-id>
        <?supplied-pmid 22826034?>
        <pub-id pub-id-type="pmid">22826034</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cha</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Drug repurposing from the perspective of pharmaceutical companies</article-title>
        <source>British journal of pharmacology</source>
        <year>2018</year>
        <volume>175</volume>
        <fpage>168</fpage>
        <lpage>180</lpage>
        <pub-id pub-id-type="doi">10.1111/bph.13798</pub-id>
        <?supplied-pmid 28369768?>
        <pub-id pub-id-type="pmid">28369768</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xue</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Review of drug repositioning approaches and resources</article-title>
        <source>International journal of biological sciences</source>
        <year>2018</year>
        <volume>14</volume>
        <fpage>1232</fpage>
        <pub-id pub-id-type="doi">10.7150/ijbs.24612</pub-id>
        <?supplied-pmid 30123072?>
        <pub-id pub-id-type="pmid">30123072</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PubChem in 2021: new data content and improved web interfaces</article-title>
        <source>Nucleic acids research</source>
        <year>2021</year>
        <volume>49</volume>
        <fpage>D1388</fpage>
        <lpage>D1395</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa971</pub-id>
        <?supplied-pmid 33151290?>
        <pub-id pub-id-type="pmid">33151290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lipscomb</surname>
            <given-names>CE</given-names>
          </name>
        </person-group>
        <article-title>Medical subject headings (MeSH)</article-title>
        <source>Bulletin of the Medical Library Association</source>
        <year>2000</year>
        <volume>88</volume>
        <fpage>265</fpage>
        <?supplied-pmid 10928714?>
        <pub-id pub-id-type="pmid">10928714</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>AP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comparative toxicogenomics database (CTD): update 2021</article-title>
        <source>Nucleic acids research</source>
        <year>2021</year>
        <volume>49</volume>
        <fpage>D1138</fpage>
        <lpage>D1143</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa891</pub-id>
        <?supplied-pmid 33068428?>
        <pub-id pub-id-type="pmid">33068428</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Köhler</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The human phenotype ontology in 2021</article-title>
        <source>Nucleic acids research</source>
        <year>2021</year>
        <volume>49</volume>
        <fpage>D1207</fpage>
        <lpage>D1217</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa1043</pub-id>
        <?supplied-pmid 33264411?>
        <pub-id pub-id-type="pmid">33264411</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update</article-title>
        <source>Nucleic acids research</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>D845</fpage>
        <lpage>D855</lpage>
        <?supplied-pmid 31680165?>
        <pub-id pub-id-type="pmid">31680165</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>GWASdb: a database for human genetic variants identified by genome-wide association studies</article-title>
        <source>Nucleic acids research</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>D1047</fpage>
        <lpage>D1054</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkr1182</pub-id>
        <?supplied-pmid 22139925?>
        <pub-id pub-id-type="pmid">22139925</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">UniProt: the universal protein knowledgebase in 2021. <italic>Nucleic Acids Research</italic><bold>49</bold>, D480–D489 (2021).</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mattingly</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Colby</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Forrest</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Boyer</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>The comparative toxicogenomics database (CTD)</article-title>
        <source>Environmental health perspectives</source>
        <year>2003</year>
        <volume>111</volume>
        <fpage>793</fpage>
        <lpage>795</lpage>
        <pub-id pub-id-type="doi">10.1289/ehp.6028</pub-id>
        <?supplied-pmid 12760826?>
        <pub-id pub-id-type="pmid">12760826</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <mixed-citation publication-type="other">Orphanet: an online rare disease and orphan drug data base. Copyright, INSERM. Available on <ext-link ext-link-type="uri" xlink:href="http://www.orpha.net">http://www.orpha.net</ext-link>. Accessed 2021/04/28 (1999).</mixed-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rehm</surname>
            <given-names>HL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClinGen—the clinical genome resource</article-title>
        <source>New England Journal of Medicine</source>
        <year>2015</year>
        <volume>372</volume>
        <fpage>2235</fpage>
        <lpage>2242</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMsr1406261</pub-id>
        <?supplied-pmid 26014595?>
        <pub-id pub-id-type="pmid">26014595</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <mixed-citation publication-type="other">The National Genomics Research and Healthcare Knowledgebase v5.1, Genomics England. (2020).</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Landrum</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClinVar: improvements to accessing data</article-title>
        <source>Nucleic acids research</source>
        <year>2020</year>
        <volume>48</volume>
        <fpage>D835</fpage>
        <lpage>D844</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz972</pub-id>
        <?supplied-pmid 31777943?>
        <pub-id pub-id-type="pmid">31777943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buniello</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019</article-title>
        <source>Nucleic acids research</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D1005</fpage>
        <lpage>D1012</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1120</pub-id>
        <?supplied-pmid 30445434?>
        <pub-id pub-id-type="pmid">30445434</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bundschus</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dejori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Stetter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tresp</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Kriegel</surname>
            <given-names>H-P</given-names>
          </name>
        </person-group>
        <article-title>Extraction of semantic biomedical relations from text using conditional random fields</article-title>
        <source>BMC bioinformatics</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>1</fpage>
        <lpage>14</lpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-9-207</pub-id>
        <pub-id pub-id-type="pmid">18173834</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bravo</surname>
            <given-names>À</given-names>
          </name>
          <name>
            <surname>Piñero</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Queralt-Rosinach</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rautschka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Furlong</surname>
            <given-names>LI</given-names>
          </name>
        </person-group>
        <article-title>Extraction of relations between genes and diseases from text and large-scale data analysis: implications for translational research</article-title>
        <source>BMC bioinformatics</source>
        <year>2015</year>
        <volume>16</volume>
        <fpage>1</fpage>
        <lpage>17</lpage>
        <pub-id pub-id-type="doi">10.1186/s12859-015-0472-9</pub-id>
        <pub-id pub-id-type="pmid">25591917</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="data">
        <name>
          <surname>Tien-Chueh</surname>
          <given-names>K</given-names>
        </name>
        <etal/>
        <year>2022</year>
        <data-title>Rare Skin Disease Database</data-title>
        <source>synapse</source>
        <pub-id pub-id-type="doi">10.7303/syn34512708</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blaydon</surname>
            <given-names>DC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion</article-title>
        <source>The American Journal of Human Genetics</source>
        <year>2011</year>
        <volume>89</volume>
        <fpage>564</fpage>
        <lpage>571</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.09.001</pub-id>
        <?supplied-pmid 21944047?>
        <pub-id pub-id-type="pmid">21944047</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moosbrugger‐Martinz</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Epidermal barrier abnormalities in exfoliative ichthyosis with a novel homozygous loss‐of‐function mutation in CSTA</article-title>
        <source>British Journal of Dermatology</source>
        <year>2015</year>
        <volume>172</volume>
        <fpage>1628</fpage>
        <lpage>1632</lpage>
        <pub-id pub-id-type="doi">10.1111/bjd.13545</pub-id>
        <?supplied-pmid 25400170?>
        <pub-id pub-id-type="pmid">25400170</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Steijlen</surname>
            <given-names>PM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic linkage of the keratin type II gene cluster with ichthyosis bullosa of Siemens and with autosomal dominant ichthyosis exfoliativa</article-title>
        <source>Journal of investigative dermatology</source>
        <year>1994</year>
        <volume>103</volume>
        <fpage>282</fpage>
        <lpage>285</lpage>
        <pub-id pub-id-type="doi">10.1111/1523-1747.ep12394335</pub-id>
        <?supplied-pmid 7521372?>
        <pub-id pub-id-type="pmid">7521372</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pigors</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Loss-of-function mutations in SERPINB8 linked to exfoliative ichthyosis with impaired mechanical stability of intercellular adhesions</article-title>
        <source>The American Journal of Human Genetics</source>
        <year>2016</year>
        <volume>99</volume>
        <fpage>430</fpage>
        <lpage>436</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.004</pub-id>
        <?supplied-pmid 27476651?>
        <pub-id pub-id-type="pmid">27476651</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Terron-Kwiatkowski</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mutation S233L in the 1B domain of keratin 1 causes epidermolytic palmoplantar keratoderma with “tonotubular” keratin</article-title>
        <source>Journal of investigative dermatology</source>
        <year>2006</year>
        <volume>126</volume>
        <fpage>607</fpage>
        <lpage>613</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.jid.5700152</pub-id>
        <?supplied-pmid 16439967?>
        <pub-id pub-id-type="pmid">16439967</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rugg</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Diagnosis and confirmation of epidermolytic palmoplantar keratoderma by the identification of mutations in keratin 9 using denaturing high‐performance liquid chromatography</article-title>
        <source>British Journal of Dermatology</source>
        <year>2002</year>
        <volume>146</volume>
        <fpage>952</fpage>
        <lpage>957</lpage>
        <pub-id pub-id-type="doi">10.1046/j.1365-2133.2002.04764.x</pub-id>
        <?supplied-pmid 12072061?>
        <pub-id pub-id-type="pmid">12072061</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shamsher</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families</article-title>
        <source>Human molecular genetics</source>
        <year>1995</year>
        <volume>4</volume>
        <fpage>1875</fpage>
        <lpage>1881</lpage>
        <pub-id pub-id-type="doi">10.1093/hmg/4.10.1875</pub-id>
        <?supplied-pmid 8595410?>
        <pub-id pub-id-type="pmid">8595410</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pavelka</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO</article-title>
        <source>Drugs Aging</source>
        <year>2016</year>
        <volume>33</volume>
        <fpage>75</fpage>
        <lpage>85</lpage>
        <pub-id pub-id-type="doi">10.1007/s40266-016-0347-4</pub-id>
        <?supplied-pmid 26849131?>
        <pub-id pub-id-type="pmid">26849131</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bruckner-Tuderman</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Newer Treatment Modalities in Epidermolysis Bullosa</article-title>
        <source>Indian Dermatol Online J</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>244</fpage>
        <lpage>250</lpage>
        <pub-id pub-id-type="doi">10.4103/idoj.IDOJ_287_18</pub-id>
        <?supplied-pmid 31149565?>
        <pub-id pub-id-type="pmid">31149565</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dogrusoz</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Belviranli</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Dilek</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>CiSE: A Circular Spring Embedder Layout Algorithm</article-title>
        <source>Ieee T Vis Comput Gr</source>
        <year>2013</year>
        <volume>19</volume>
        <fpage>953</fpage>
        <lpage>966</lpage>
        <pub-id pub-id-type="doi">10.1109/Tvcg.2012.178</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dogrusoz</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Giral</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Cetintas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Civril</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Demir</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>A layout algorithm for undirected compound graphs</article-title>
        <source>Inform Sciences</source>
        <year>2009</year>
        <volume>179</volume>
        <fpage>980</fpage>
        <lpage>994</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ins.2008.11.017</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Franz</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cytoscape. js: a graph theory library for visualisation and analysis</article-title>
        <source>Bioinformatics</source>
        <year>2016</year>
        <volume>32</volume>
        <fpage>309</fpage>
        <lpage>311</lpage>
        <?supplied-pmid 26415722?>
        <pub-id pub-id-type="pmid">26415722</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
